Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Non-small Cell Lung Cancer (NSCLC) - Three Course Suite
The Non-small Cell Lung Cancer (NSCLC): Three Course Suite suite (see below) comprises the followng courses:
> Non-small Cell Lung Cancer: Cause
> Non-small Cell Lung Cancer: Diagnosis
> Non-small Cell Lung Cancer: Treatment
CME Credits: 3 credits (as suggested by the California Medical Association)
Duration: About 3 hours
Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. The three courses in this suite discuss the cause, diagnosis, and treatment of non-small cell lung cancer.
Each Online Training Course or Professional Designation Program listed below comes complete with;
> 24 hour access to the course for 90 days,
> a printable PDF file including the notes to the course,
> a test used to measure your understanding of the material provided in the course, and
> a Certificate of Completion once you have passed a course, or;
> a Certificate of Professional Designation if you are enrolling in a Professional Designation program
Course Organization, Accreditations, Certification, FAQs
Open DEMO couorse
Price
Per Person $350.00
Corporate 5 employees $1,225.00
Non-small Cell Lung Cancer - Cause (Course)
Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. This course presents scientific information and statistics about non-small cell lung cancer and NSCLC classifications.
Non-small Cell Lung Cancer - Diagnosis (Course)
Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. This course details symptoms, diagnostic procedures, and imaging devices used to detect lung cancer.
Non-small Cell Lung Cancer - Treatment (Course)
Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. This course describes the various treatment options and prognostic outcomes for the various stages and types of NSCLC.
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.